IMM 23.0% 33.5¢ immutep limited

cancer immunotherapy hottest theme

  1. 978 Posts.


    I hope all the market hype has not dimmed people's memories about how Prima is using cutting edge ex vivo cancer immunotherapy vaccines which, along with Dendreon, are the only 2 companies so doing!

    extract from article today:

    "The hottest theme at this year's 2010 ASCO (American Society of Clinical Oncology) annual meeting was without a doubt cancer immunotherapy, an old paradigm that deals with redirecting the patient's immune system against tumors. After decades of failures, this concept is finally proving itself useful.

    There are basically two approaches: 1) cancer vaccines that aim at eliciting an immune response against specific targets on cancer cells and 2) immunomodulatory drugs that aim at stimulating the immune system in a more general manner (not target specific)."

    The undisputed leader in cancer vaccines is Dendreon (DNDN), which currently has the only FDA approved cancer vaccine.

    Source:http://www.istockanalyst.com/article/viewarticle/articleid/4279078
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
33.5¢
Change
-0.100(23.0%)
Mkt cap ! $486.6M
Open High Low Value Volume
39.0¢ 40.0¢ 23.0¢ $16.23M 50.19M

Buyers (Bids)

No. Vol. Price($)
4 704297 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.5¢ 102135 2
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.